- Article metrics
- Last updated: Tue, 14 Oct 2025 9:14:55 Z
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer
Access & Citations
-
- 1633
- Article Accesses
-
- 27
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.